EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Acrobiosystems Co's enterprise value is ¥3,046.6 Mil.
Acrobiosystems Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥148.5 Mil. Therefore, Acrobiosystems Co's EV-to-EBITDA for today is 20.52.
The historical rank and industry rank for Acrobiosystems Co's EV-to-EBITDA or its related term are showing as below:
SZSE:301080'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 15.42 Med: 33.59 Max: 99.53
Current: 20.52
During the past 7 years, the highest EV-to-EBITDA of Acrobiosystems Co was 99.53. The lowest was 15.42. And the median was 33.59.
SZSE:301080's EV-to-EBITDA is ranked worse than 66.81% of 455
companies
in the Biotechnology industry
Industry Median: 10.35
vs SZSE:301080: 20.52
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Acrobiosystems Co EV-to-EBITDA Historical Data
The historical data trend for Acrobiosystems Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Acrobiosystems Co's EV-to-EBITDA
For the Biotechnology subindustry, Acrobiosystems Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acrobiosystems Co's EV-to-EBITDA Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Acrobiosystems Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Acrobiosystems Co's EV-to-EBITDA falls into.
Acrobiosystems Co's current Enterprise Value is ¥3,046.6 Mil.
Acrobiosystems Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥148.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acrobiosystems Co (SZSE:301080) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Acrobiosystems Co's PE Ratio for today is calculated as:
Acrobiosystems Co's share price for today is ¥40.98.
Acrobiosystems Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.154.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Acrobiosystems Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Acrobiosystems Co (SZSE:301080) Business Description
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:301080 has been successfully added to your 